揭开“消瘤”补剂真相：成分功效无证据支持，“进口”身份存疑

Core Viewpoint - The article highlights the misleading marketing of dietary supplements claiming to treat uterine fibroids, emphasizing the lack of clinical evidence supporting their efficacy and the potential risks associated with their use [1][2][3]. Group 1: Product Claims and Marketing Tactics - Various dietary supplements are marketed as "special drugs" for uterine fibroids, using terms like "imported treatment" and "special effects" to attract consumers [3][9]. - Specific products mentioned include Anpical Uterine Fibroids capsules, Anpical Soybean Isoflavone care capsules, Anpical Pelvic Floor Muscle capsules, and Fele Women's Immune capsules, all claiming to reduce fibroid size and promote healing [3][10]. - The marketing strategies include mimicking imported products and using customer testimonials to create a false sense of effectiveness [10][11]. Group 2: Scientific Evidence and Expert Opinions - Experts, including Dr. Tang Zhijian, assert that the ingredients in these supplements, such as myo-inositol, lycopene, and soy isoflavones, lack clinical trial support for their claimed benefits in treating uterine fibroids [2][17][18]. - Research indicates that soy isoflavones may actually stimulate fibroid growth rather than reduce it, contradicting the claims made by marketers [18][19]. - The article cites various studies that criticize the exaggerated claims of dietary supplements, emphasizing the need for consumers to rely on scientific evidence and professional medical advice [19][20]. Group 3: Regulatory and Ethical Concerns - The marketing practices of these supplements may violate Chinese advertising laws, which prohibit false claims regarding medical efficacy [19][20]. - The article points out that the blending of food and drug attributes in marketing these supplements can mislead consumers and potentially harm their health by delaying proper treatment [19][20].